188 related articles for article (PubMed ID: 11973258)
1. A new delivery system for 5-fluorouracil using prodrug and converting enzyme.
Akimoto M; Miyahara T; Arai J; Akimoto A; Hamada H; Yoshida Y; Yoshimura N
Br J Ophthalmol; 2002 May; 86(5):581-6. PubMed ID: 11973258
[TBL] [Abstract][Full Text] [Related]
2. Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.
Garcia-Sanchez F; Pizzorno G; Fu SQ; Nanakorn T; Krause DS; Liang J; Adams E; Leffert JJ; Yin LH; Cooperberg MR; Hanania E; Wang WL; Won JH; Peng XY; Cote R; Brown R; Burtness B; Giles R; Crystal R; Deisseroth AB
Blood; 1998 Jul; 92(2):672-82. PubMed ID: 9657770
[TBL] [Abstract][Full Text] [Related]
3. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
[TBL] [Abstract][Full Text] [Related]
5. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
6. Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice.
Torimura T; Ueno T; Taniguchi E; Masuda H; Iwamoto H; Nakamura T; Inoue K; Hashimoto O; Abe M; Koga H; Barresi V; Nakashima E; Yano H; Sata M
Cancer Sci; 2012 Mar; 103(3):542-8. PubMed ID: 22151662
[TBL] [Abstract][Full Text] [Related]
7. Selective in vivo radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells transduced with the E. coli cytosine deaminase (CD) gene.
Gabel M; Kim JH; Kolozsvary A; Khil M; Freytag S
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):883-7. PubMed ID: 9652853
[TBL] [Abstract][Full Text] [Related]
8. Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.
Kievit E; Nyati MK; Ng E; Stegman LD; Parsels J; Ross BD; Rehemtulla A; Lawrence TS
Cancer Res; 2000 Dec; 60(23):6649-55. PubMed ID: 11118048
[TBL] [Abstract][Full Text] [Related]
9. The potential therapeutic gain of radiation-associated gene therapy with the suicide gene cytosine deaminase.
Lambin P; Nuyts S; Landuyt W; Theys J; De Bruijn E; Anné J; Van Mellaert L; Fowler J
Int J Radiat Biol; 2000 Mar; 76(3):285-93. PubMed ID: 10757308
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation.
Anello R; Cohen S; Atkinson G; Hall SJ
J Urol; 2000 Dec; 164(6):2173-7. PubMed ID: 11061950
[TBL] [Abstract][Full Text] [Related]
11. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.
Chung-Faye GA; Chen MJ; Green NK; Burton A; Anderson D; Mautner V; Searle PF; Kerr DJ
Gene Ther; 2001 Oct; 8(20):1547-54. PubMed ID: 11704815
[TBL] [Abstract][Full Text] [Related]
12. Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase.
Hamstra DA; Rice DJ; Fahmy S; Ross BD; Rehemtulla A
Hum Gene Ther; 1999 Aug; 10(12):1993-2003. PubMed ID: 10466633
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine.
Wallace PM; MacMaster JF; Smith VF; Kerr DE; Senter PD; Cosand WL
Cancer Res; 1994 May; 54(10):2719-23. PubMed ID: 8168103
[TBL] [Abstract][Full Text] [Related]
14. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine.
Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG
Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418
[TBL] [Abstract][Full Text] [Related]
15. Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil.
Kuriyama S; Masui K; Sakamoto T; Nakatani T; Kikukawa M; Tsujinoue H; Mitoro A; Yamazaki M; Yoshiji H; Fukui H; Ikenaka K; Mullen CA; Tsujii T
Anticancer Res; 1998; 18(5A):3399-406. PubMed ID: 9858915
[TBL] [Abstract][Full Text] [Related]
16. Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine.
Haberkorn U; Oberdorfer F; Gebert J; Morr I; Haack K; Weber K; Lindauer M; van Kaick G; Schackert HK
J Nucl Med; 1996 Jan; 37(1):87-94. PubMed ID: 8544010
[TBL] [Abstract][Full Text] [Related]
17. Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models.
Stackhouse MA; Pederson LC; Grizzle WE; Curiel DT; Gebert J; Haack K; Vickers SM; Mayo MS; Buchsbaum DJ
Gene Ther; 2000 Jun; 7(12):1019-26. PubMed ID: 10871750
[TBL] [Abstract][Full Text] [Related]
18. PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer.
Chen Z; Penet MF; Krishnamachary B; Banerjee SR; Pomper MG; Bhujwalla ZM
Biomaterials; 2016 Feb; 80():57-67. PubMed ID: 26706476
[TBL] [Abstract][Full Text] [Related]
19. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration.
Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H
J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940
[TBL] [Abstract][Full Text] [Related]
20. Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent.
King I; Bermudes D; Lin S; Belcourt M; Pike J; Troy K; Le T; Ittensohn M; Mao J; Lang W; Runyan JD; Luo X; Li Z; Zheng LM
Hum Gene Ther; 2002 Jul; 13(10):1225-33. PubMed ID: 12133275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
